|
What is are Silicone Breast Implants?
The three types of silicone gel-filled breast implants are as follows:
One type is a single lumen implant that is prefilled by the manufacturer
with a fixed volume of silicone gel.
A second type is a double lumen implant with (1) an inner lumen
prefilled by the manufacturer with a fixed volume of silicone gel
and (2) an outer lumen that is filled during the operation with
a fixed volume of saline through a valve.
A third type is a double lumen implant with (1) an outer lumen
prefilled by the manufacturer with a fixed volume of silicone gel
and (2) an inner lumen that is filled during the operation with
saline through a valve. This type of implant allows for adjustments
of the saline volume after the operation.
A silicone gel-filled breast implant has a silicone rubber shell
with the same general composition as shown in the Saline-Filled
Breast Implants section above.
The filler is silicone gel that has the general composition of:
silicone oil
cured polymeric (large) silicones
small amounts of uncured large and smaller silicones
minute amounts (parts per million) of metals, including a metal
catalyst (usually platinum). (A catalyst is something that causes
a change in material.)
Prior to 1991, silicone gel-filled breast implants were sold on
the market as either preamendments devices (they were on the market
prior to May 1976) or as 510(k)-cleared devices. In April 1991,
FDA issued a regulation that required that all silicone gel-filled
breast implants be PMA-approved to be sold on the market. However,
those companies that had a preamendments or 510(k)-cleared silicone
gel-filled breast implants and submitted their PMA within 90 days
of the April 1991 regulation were allowed to keep their device on
the market until the final decision/actions were made in April 1992.
Since April 1992, a silicone gel-filled breast implant must be PMA-approved
to be sold on the market.
As of the date of this handbook, no company has PMA approval for
a silicone gel-filled breast implant. Therefore, all silicone gel-filled
breast implants are considered investigational. For a woman to receive
a silicone gel-filled breast implant in the U.S., she must enroll
in an IDE study or an adjunct study.
An adjunct study is different from the IDE study in terms of its purpose
and study design. In April 1992, FDA determined that the silicone
gel-filled breast implant PMAs submitted in 1991 did not include adequate
safety data to support PMA approval. However, FDA believed that there
was a public health need to have breast implants available for reconstruction
and revision patients. Therefore, companies that had not withdrawn
their PMAs prior to the April 1992 decision were given the opportunity
to submit an adjunct study protocol, for FDA approval, to address
the public health need. Only Mentor Corporation and Inamed Corporation
received approvals for their adjunct studies.
Adjunct studies are limited to reconstruction and revision patients.
Women who want silicone gel-filled implants for augmentation (cosmetic
reasons) cannot be enrolled in an adjunct study. New reconstruction
and revision patients are continuously being enrolled in the adjunct
studies because there is no limit on the number of patients or the
number of sites. Each woman who participates in an adjunct study
must give informed consent.5 The safety data collected in an adjunct
study are used as supplemental data to support a future PMA.
Additional Liposuction Research:
Saline Breast Implants
| Silicone Breast Implants
| Breast Augmentation Risks
| Breast Augmentation Costs
| Breast Augmentation
Before & After | Choosing
a Breast Augmentation Surgeon | Choosing
a Breast Implant | Breast
Reconstruction with Breast Implants | Breast
Reconstruction with Tissue Flaps | Questions
for Your Breast Augmentation Surgeon | Questions
for Your Breast Reconstruction Surgeon | Breast
Augmentation Glossary
|